{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:32:04Z","timestamp":1789497124455,"version":"build-2803163510"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019725","name":"Deanship of Scientific Research, Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1445"],"award-info":[{"award-number":["PSAU\/2023\/R\/1445"]}],"id":[{"id":"10.13039\/100019725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10072-024-07871-4","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T03:37:30Z","timestamp":1733456250000},"page":"1489-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nanomedicine in the treatment of Alzheimer\u2019s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology"],"prefix":"10.1007","volume":"46","author":[{"given":"Nana","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Ali-Khiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Ghavamikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyedAbbas","family":"Pakmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Sotoudegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hjazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad Kohandel","family":"Gargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa Kohandel","family":"Gargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Behnamrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9004-7482","authenticated-orcid":false,"given":"Mohammadreza","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Elhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Saffarfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Nourizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"7871_CR1","doi-asserted-by":"publisher","first-page":"14044","DOI":"10.3390\/ijms241814044","volume":"24","author":"N Puranik","year":"2023","unstructured":"Puranik N, Yadav D, Song M (2023) Advancements in the application of Nanomedicine in Alzheimer\u2019s Disease: a therapeutic perspective. Int J Mol Sci 24:14044. https:\/\/doi.org\/10.3390\/ijms241814044","journal-title":"Int J Mol Sci"},{"key":"7871_CR2","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/biomedicines11061752","volume":"11","author":"SN Mir Najib Ullah","year":"2023","unstructured":"Mir Najib Ullah SN, Afzal O, Altamimi ASA, Ather H, Sultana S, Almalki WH et al (2023) Nanomedicine in the management of Alzheimer\u2019s Disease: state-of-the-art. Biomedicines 11:1752. https:\/\/doi.org\/10.3390\/biomedicines11061752","journal-title":"Biomedicines"},{"key":"7871_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/bs.coac.2023.09.011","author":"P Rathor","year":"2024","unstructured":"Rathor P (2024) Metabolomic of neurodegenerative disorder: Alzheimer\u2019s disease. Compr Anal Chem. https:\/\/doi.org\/10.1016\/bs.coac.2023.09.011","journal-title":"Compr Anal Chem"},{"key":"7871_CR4","doi-asserted-by":"publisher","unstructured":"Akhtar MS, Khobrani M, Pottoo FH, ur Rahman J (2023) Alzheimer\u2019s disease: Pathogenesis and therapeutics advancements targeting potential neurotransmitters and neuronal peptides. Neurochem Syst Signal Mol Networks 71\u201392. https:\/\/doi.org\/10.1201\/9780429265198-7","DOI":"10.1201\/9780429265198-7"},{"key":"7871_CR5","doi-asserted-by":"publisher","unstructured":"Castellani RJ, Plascencia-Villa G, Perry G, Handb, Neurotoxicity (2023) Second Ed., 3, p. 1709\u20131728. https:\/\/doi.org\/10.1007\/978-3-031-15080-7_162","DOI":"10.1007\/978-3-031-15080-7_162"},{"key":"7871_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-323-85538-9.00015-8","volume":"192","author":"SL Sensi","year":"2023","unstructured":"Sensi SL, Russo M, Tiraboschi P (2023) Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: convergence or divergence? Lessons from Alzheimer\u2019s disease and synucleinopathies. Handb Clin Neurol 192:187\u2013218. https:\/\/doi.org\/10.1016\/B978-0-323-85538-9.00015-8","journal-title":"Handb Clin Neurol"},{"key":"7871_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-981-13-9636-6_13","volume-title":"Neurobiological mechanisms involved in the pathogenesis of Alzheimer\u2019s Disease. Biol. Diagnostic ther. Adv. Alzheimer\u2019s Dis","author":"FA Mir","year":"2019","unstructured":"Mir FA, Rizvi ZA (2019) Neurobiological mechanisms involved in the pathogenesis of Alzheimer\u2019s Disease. Biol. Diagnostic ther. Adv. Alzheimer\u2019s Dis. Springer Singapore, Singapore, pp 235\u2013269. https:\/\/doi.org\/10.1007\/978-981-13-9636-6_13"},{"key":"7871_CR8","doi-asserted-by":"publisher","unstructured":"Bhaskar K, Lamb BT (2012) The Role of A\u03b2 and Tau Oligomers in the Pathogenesis of Alzheimer\u2019s Disease. Non-fibrillar Amyloidogenic Protein Assem. - Common Cytotoxins Underlying Degener. Dis., vol. 9789400727, Dordrecht: Springer Netherlands; pp. 135\u201388. https:\/\/doi.org\/10.1007\/978-94-007-2774-8_5","DOI":"10.1007\/978-94-007-2774-8_5"},{"key":"7871_CR9","doi-asserted-by":"publisher","unstructured":"Wang H-Y, Khan A (2020) A\u03b242-\u03b17-like nicotinic acetylcholine receptors and Alzheimer\u2019s disease. Genet Neurol Behav Diet Dement 457\u2013471. https:\/\/doi.org\/10.1016\/B978-0-12-815868-5.00029-3","DOI":"10.1016\/B978-0-12-815868-5.00029-3"},{"key":"7871_CR10","doi-asserted-by":"publisher","unstructured":"Serrano E, Sanz PG, Barrantes FJ (2021) The Impact of Apolipoprotein E Allelic Variants on Alzheimer\u2019s Disease. Psychiatry Neurosci. Updat., Cham: Springer International Publishing; pp. 397\u2013418. https:\/\/doi.org\/10.1007\/978-3-030-61721-9_29","DOI":"10.1007\/978-3-030-61721-9_29"},{"key":"7871_CR11","doi-asserted-by":"publisher","unstructured":"Hodges J, Dementia. (2017) CRC Press; https:\/\/doi.org\/10.1201\/9781315381572","DOI":"10.1201\/9781315381572"},{"key":"7871_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/pharmaceutics15051399","volume":"15","author":"R Tal\u00e9ns-Visconti","year":"2023","unstructured":"Tal\u00e9ns-Visconti R, de Juli\u00e1n-Ortiz JV, Vila-Bus\u00f3 O, Diez-Sales O, N\u00e1cher A (2023) Intranasal Drug Administration in Alzheimer-Type Dementia: towards clinical applications. Pharmaceutics 15:1399. https:\/\/doi.org\/10.3390\/pharmaceutics15051399","journal-title":"Pharmaceutics"},{"key":"7871_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/bioengineering11010045","volume":"11","author":"KL Nystuen","year":"2024","unstructured":"Nystuen KL, McNamee SM, Akula M, Holton KM, DeAngelis MM, Haider NB (2024) Alzheimer\u2019s Disease: models and molecular mechanisms informing Disease and treatments. Bioengineering 11:45. https:\/\/doi.org\/10.3390\/bioengineering11010045","journal-title":"Bioengineering"},{"key":"7871_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-023-00636-1","volume":"18","author":"SP Yu","year":"2023","unstructured":"Yu SP, Jiang MQ, Shim SS, Pourkhodadad S, Wei L (2023) Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease. Mol Neurodegener 18:43. https:\/\/doi.org\/10.1186\/s13024-023-00636-1","journal-title":"Mol Neurodegener"},{"key":"7871_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.seda.2023.08.018","volume":"45","author":"A Hussain","year":"2023","unstructured":"Hussain A, Bloemer J (2023) Side effects of drugs used in the treatment of Alzheimer\u2019s disease. Side Eff Drugs Annu 45:27\u201332. https:\/\/doi.org\/10.1016\/bs.seda.2023.08.018","journal-title":"Side Eff Drugs Annu"},{"key":"7871_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1039\/d2na00625a","volume":"5","author":"X Shao","year":"2022","unstructured":"Shao X, Yan C, Wang C, Wang C, Cao Y, Zhou Y et al (2022) Advanced nanomaterials for modulating Alzheimer\u2019s related amyloid aggregation. Nanoscale Adv 5:46\u201380. https:\/\/doi.org\/10.1039\/d2na00625a","journal-title":"Nanoscale Adv"},{"key":"7871_CR17","doi-asserted-by":"publisher","first-page":"2269331","DOI":"10.1080\/13510002.2023.2269331","volume":"28","author":"VK Yadav","year":"2023","unstructured":"Yadav VK, Choudhary N, Gacem A, Verma RK, Abul Hasan M, Tarique Imam M et al (2023) Deeper insight into ferroptosis: association with Alzheimer\u2019s, Parkinson\u2019s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis. Redox Rep 28:2269331. https:\/\/doi.org\/10.1080\/13510002.2023.2269331","journal-title":"Redox Rep"},{"key":"7871_CR18","doi-asserted-by":"publisher","first-page":"202302673","DOI":"10.1002\/adfm.202302673","volume":"33","author":"S Abdullah","year":"2023","unstructured":"Abdullah S, Al, Najm L, Ladouceur L, Ebrahimi F, Shakeri A, Al-Jabouri N et al (2023) Functional nanomaterials for the diagnosis of Alzheimer\u2019s Disease: recent progress and future perspectives. Adv Funct Mater 33:202302673. https:\/\/doi.org\/10.1002\/adfm.202302673","journal-title":"Adv Funct Mater"},{"key":"7871_CR19","doi-asserted-by":"publisher","first-page":"100789","DOI":"10.1016\/j.mtbio.2023.100789","volume":"22","author":"T Yin","year":"2023","unstructured":"Yin T, Liu Y, He B, Gong B, Chu J, Gao C et al (2023) Cell primitive-based biomimetic nanomaterials for Alzheimer\u2019s disease targeting and therapy. Mater Today Bio 22:100789. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100789","journal-title":"Mater Today Bio"},{"key":"7871_CR20","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.3390\/ijms242216288","volume":"24","author":"AE Alkhalifa","year":"2023","unstructured":"Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A (2023) Blood\u2013brain barrier breakdown in Alzheimer\u2019s Disease: mechanisms and targeted strategies. Int J Mol Sci 24:16288. https:\/\/doi.org\/10.3390\/ijms242216288","journal-title":"Int J Mol Sci"},{"key":"7871_CR21","doi-asserted-by":"publisher","unstructured":"Gupta S, Dhanda S, Sandhir R (2019) Anatomy and physiology of blood-brain barrier. Brain Target Drug Deliv Syst 7\u201331. https:\/\/doi.org\/10.1016\/B978-0-12-814001-7.00002-0","DOI":"10.1016\/B978-0-12-814001-7.00002-0"},{"key":"7871_CR22","doi-asserted-by":"publisher","unstructured":"Bors LA, Erd\u0151 F (2021) The blood-brain barrier in aging. Factors Affect. Neurol. Aging, Elsevier; pp. 439\u201349. https:\/\/doi.org\/10.1016\/B978-0-12-817990-1.00038-X","DOI":"10.1016\/B978-0-12-817990-1.00038-X"},{"key":"7871_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/978-981-19-1379-2_24","volume-title":"Application of Organ-on-Chip in blood brain barrier model. Microfluid. Multi organs Chip","author":"P Vatsa","year":"2022","unstructured":"Vatsa P, Pant AB (2022) Application of Organ-on-Chip in blood brain barrier model. Microfluid. Multi organs Chip. Springer Nature Singapore, Singapore, pp 589\u2013626. https:\/\/doi.org\/10.1007\/978-981-19-1379-2_24"},{"key":"7871_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-0716-3429-5_10","volume":"2711","author":"OY Waithe","year":"2024","unstructured":"Waithe OY, Shaji CA, Childs EW, Tharakan B (2024) Determination of blood-brain barrier hyperpermeability using Intravital Microscopy. Methods Mol Biol 2711:117\u2013127. https:\/\/doi.org\/10.1007\/978-1-0716-3429-5_10","journal-title":"Methods Mol Biol"},{"key":"7871_CR25","doi-asserted-by":"publisher","first-page":"1926190","DOI":"10.1080\/21688370.2021.1926190","volume":"9","author":"AA Scalise","year":"2021","unstructured":"Scalise AA, Kakogiannos N, Zanardi F, Iannelli F, Giannotta M (2021) The blood\u2013brain and gut\u2013vascular barriers: from the perspective of claudins. Tissue Barriers 9:1926190. https:\/\/doi.org\/10.1080\/21688370.2021.1926190","journal-title":"Tissue Barriers"},{"key":"7871_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/genes14051085","volume":"14","author":"RF Nasyrova","year":"2023","unstructured":"Nasyrova RF, Shnayder NA, Osipova SM, Khasanova AK, Efremov IS, Al-Zamil M et al (2023) Genetic predictors of antipsychotic efflux impairment via blood-brain barrier: role of Transport proteins. Genes (Basel) 14:1085. https:\/\/doi.org\/10.3390\/genes14051085","journal-title":"Genes (Basel)"},{"key":"7871_CR27","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/pharmaceutics14102167","volume":"14","author":"S Latif","year":"2022","unstructured":"Latif S, Kang Y-S (2022) Blood\u2013brain barrier solute Carrier transporters and Motor Neuron Disease. Pharmaceutics 14:2167. https:\/\/doi.org\/10.3390\/pharmaceutics14102167","journal-title":"Pharmaceutics"},{"key":"7871_CR28","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/pharmaceutics15102473","volume":"15","author":"MM Parvez","year":"2023","unstructured":"Parvez MM, Sadighi A, Ahn Y, Keller SF, Enoru JO (2023) Uptake transporters at the blood\u2013brain barrier and their role in Brain Drug Disposition. Pharmaceutics 15:2473. https:\/\/doi.org\/10.3390\/pharmaceutics15102473","journal-title":"Pharmaceutics"},{"key":"7871_CR29","doi-asserted-by":"publisher","unstructured":"Bhavsar N, Saxena B, Shah J (2022) Blood-brain barrier and central nervous system drug delivery: challenges and opportunities. Nanocarriers for drug-targeting brain tumors. 31\u201348. https:\/\/doi.org\/10.1016\/B978-0-323-90773-6.00005-1","DOI":"10.1016\/B978-0-323-90773-6.00005-1"},{"key":"7871_CR30","doi-asserted-by":"publisher","unstructured":"Omidi Y, Omidian H, Kwon Y, Castejon A (2022) Blood\u2013brain barrier and nanovesicles for brain-targeting drug delivery. Appl Nanovesicular Drug Deliv 167\u2013199. https:\/\/doi.org\/10.1016\/B978-0-323-91865-7.00007-9","DOI":"10.1016\/B978-0-323-91865-7.00007-9"},{"key":"7871_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/164_2020_403","volume":"273","author":"HCC Helms","year":"2022","unstructured":"Helms HCC, Kristensen M, Saaby L, Fricker G, Brodin B (2022) Drug delivery strategies to overcome the blood\u2013brain barrier (BBB). Handb Exp Pharmacol 273:151\u2013183. https:\/\/doi.org\/10.1007\/164_2020_403","journal-title":"Handb Exp Pharmacol"},{"key":"7871_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pmbts.2022.09.005","volume":"196","author":"I Kawahata","year":"2023","unstructured":"Kawahata I, Fukunaga K (2023) Endocytosis of dopamine receptor: signaling in brain. Prog Mol Biol Transl Sci 196:99\u2013111. https:\/\/doi.org\/10.1016\/bs.pmbts.2022.09.005","journal-title":"Prog Mol Biol Transl Sci"},{"key":"7871_CR33","doi-asserted-by":"publisher","first-page":"703545","DOI":"10.1155\/2013\/703545","volume":"2013","author":"G Xiao","year":"2013","unstructured":"Xiao G, Gan L-S (2013) Receptor-mediated endocytosis and brain delivery of Therapeutic Biologics. Int J Cell Biol 2013:703545. https:\/\/doi.org\/10.1155\/2013\/703545","journal-title":"Int J Cell Biol"},{"key":"7871_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2174\/1871527321666220420133059","volume":"22","author":"F Mazahir","year":"2022","unstructured":"Mazahir F, Yadav AK (2022) Recent trends in Nano-Particulate carriers for the diagnosis and treatment of Alzheimer\u2019s Disease. CNS Neurol Disord - Drug Targets 22:477\u2013499. https:\/\/doi.org\/10.2174\/1871527321666220420133059","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"7871_CR35","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1039\/d2bm00010e","volume":"10","author":"JY Oh","year":"2022","unstructured":"Oh JY, Yang G, Choi E, Ryu JH (2022) Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency. Biomater Sci 10:1448\u20131455. https:\/\/doi.org\/10.1039\/d2bm00010e","journal-title":"Biomater Sci"},{"key":"7871_CR36","doi-asserted-by":"publisher","first-page":"101725","DOI":"10.1016\/j.biologicals.2023.101725","volume":"85","author":"L Samananda Singh","year":"2024","unstructured":"Samananda Singh L (2024) Nano-Emulsion encapsulation for the efficient delivery of bacteriophage therapeutics. Biologicals 85:101725. https:\/\/doi.org\/10.1016\/j.biologicals.2023.101725","journal-title":"Biologicals"},{"key":"7871_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A et al (2018) Impact of particle size and Polydispersity Index on the clinical applications of Lipidic Nanocarrier systems. Pharmaceutics 10:57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057","journal-title":"Pharmaceutics"},{"key":"7871_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/molecules28020841","volume":"28","author":"M Bazi Alahri","year":"2023","unstructured":"Bazi Alahri M, Jibril Ibrahim A, Barani M, Arkaban H, Shadman SM, Salarpour S et al (2023) Management of Brain Cancer and Neurodegenerative disorders with polymer-based nanoparticles as a biocompatible platform. Molecules 28:841. https:\/\/doi.org\/10.3390\/molecules28020841","journal-title":"Molecules"},{"key":"7871_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/nano12142337","volume":"12","author":"S Martano","year":"2022","unstructured":"Martano S, De Matteis V, Cascione M, Rinaldi R (2022) Inorganic nanomaterials versus polymer-based nanoparticles for overcoming neurodegeneration. Nanomaterials 12:2337. https:\/\/doi.org\/10.3390\/nano12142337","journal-title":"Nanomaterials"},{"key":"7871_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jfb10010004","volume":"10","author":"E Calzoni","year":"2019","unstructured":"Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C (2019) Biocompatible polymer nanoparticles for drug delivery applications in Cancer and neurodegenerative disorder therapies. J Funct Biomater 10:4. https:\/\/doi.org\/10.3390\/jfb10010004","journal-title":"J Funct Biomater"},{"key":"7871_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/ADR-220112","volume":"7","author":"A Behera","year":"2023","unstructured":"Behera A, Sa N, Pradhan SP, Swain S, Sahu PK (2023) Metal nanoparticles in Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis Rep 7:791\u2013810. https:\/\/doi.org\/10.3233\/ADR-220112","journal-title":"J Alzheimer\u2019s Dis Rep"},{"key":"7871_CR42","doi-asserted-by":"publisher","first-page":"102168","DOI":"10.1016\/j.nantod.2024.102168","volume":"55","author":"X Zhang","year":"2024","unstructured":"Zhang X, Hu H, Li Q, Zhao Y, Zhang Z, Zhao S et al (2024) Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer\u2019s disease. Nano Today 55:102168. https:\/\/doi.org\/10.1016\/j.nantod.2024.102168","journal-title":"Nano Today"},{"key":"7871_CR43","doi-asserted-by":"publisher","first-page":"0180","DOI":"10.34133\/research.0180","volume":"6","author":"Q Huang","year":"2023","unstructured":"Huang Q, Jiang C, Xia X, Wang Y, Yan C, Wang X et al (2023) Pathological BBB Crossing Melanin-like Nanoparticles as metal-ion chelators and Neuroinflammation regulators against Alzheimer\u2019s Disease. Research 6:0180. https:\/\/doi.org\/10.34133\/research.0180","journal-title":"Research"},{"key":"7871_CR44","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1021\/acsnano.2c08094","volume":"16","author":"Y Han","year":"2022","unstructured":"Han Y, Yi H, Wang Y, Li Z, Chu X, Jiang JH (2022) Ultrathin zinc selenide nanoplatelets boosting photoacoustic imaging of in situ Copper Exchange in Alzheimer\u2019s Disease mice. ACS Nano 16:19053\u201319066. https:\/\/doi.org\/10.1021\/acsnano.2c08094","journal-title":"ACS Nano"},{"key":"7871_CR45","doi-asserted-by":"publisher","first-page":"120483","DOI":"10.1016\/j.biomaterials.2020.120483","volume":"267","author":"L Gong","year":"2021","unstructured":"Gong L, Zhang X, Ge K, Yin Y, Machuki JO, Yang Y et al (2021) Carbon Nitride-based nanocaptor: an intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer\u2019s disease. Biomaterials 267:120483. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120483","journal-title":"Biomaterials"},{"key":"7871_CR46","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41467-019-11762-0","volume":"10","author":"I Javed","year":"2019","unstructured":"Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A et al (2019) Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun 10:3780. https:\/\/doi.org\/10.1038\/s41467-019-11762-0","journal-title":"Nat Commun"},{"key":"7871_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.msec.2019.03.086","volume":"101","author":"A Girigoswami","year":"2019","unstructured":"Girigoswami A, Ramalakshmi M, Akhtar N, Metkar SK, Girigoswami K (2019) ZnO Nanoflower petals mediated amyloid degradation - an in vitro electrokinetic potential approach. Mater Sci Eng C 101:169\u2013178. https:\/\/doi.org\/10.1016\/j.msec.2019.03.086","journal-title":"Mater Sci Eng C"},{"key":"7871_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.actbio.2016.09.010","volume":"46","author":"L Yang","year":"2016","unstructured":"Yang L, Yin T, Liu Y, Sun J, Zhou Y, Liu J (2016) Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer\u2019s disease treatment. Acta Biomater 46:177\u2013190. https:\/\/doi.org\/10.1016\/j.actbio.2016.09.010","journal-title":"Acta Biomater"},{"key":"7871_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnsyn.2020.00020","volume":"12","author":"L Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2020","unstructured":"Ord\u00f3\u00f1ez-Guti\u00e9rrez L, Wandosell F (2020) Nanoliposomes as a Therapeutic Tool for Alzheimer\u2019s Disease. Front Synaptic Neurosci 12:20. https:\/\/doi.org\/10.3389\/fnsyn.2020.00020","journal-title":"Front Synaptic Neurosci"},{"key":"7871_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2217\/clp.14.33","volume":"9","author":"SG Antimisiaris","year":"2014","unstructured":"Antimisiaris SG (2014) Potential of nanoliposomes for the therapy and\/or diagnosis of Alzheimer\u2019s disease: recent progress. Clin Lipidol 9:477\u2013481. https:\/\/doi.org\/10.2217\/clp.14.33","journal-title":"Clin Lipidol"},{"key":"7871_CR51","doi-asserted-by":"publisher","first-page":"e01088","DOI":"10.1016\/j.heliyon.2018.e01088","volume":"4","author":"M Danaei","year":"2018","unstructured":"Danaei M, Kalantari M, Raji M, Samareh Fekri H, Saber R, Asnani GP et al (2018) Probing nanoliposomes using single particle analytical techniques: effect of excipients, solvents, phase transition and zeta potential. Heliyon 4:e01088. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e01088","journal-title":"Heliyon"},{"key":"7871_CR52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/1389557516666161031120752","volume":"18","author":"A Zoghi","year":"2018","unstructured":"Zoghi A, Khosravi-Darani K, Omri A (2018) Process variables and design of experiments in Liposome and Nanoliposome Research. Mini-Reviews Med Chem 18:324\u2013344. https:\/\/doi.org\/10.2174\/1389557516666161031120752","journal-title":"Mini-Reviews Med Chem"},{"key":"7871_CR53","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s12272-014-0539-6","volume":"38","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Zhang G, Rao Z, Yang Y, Zhou Q, Qin H et al (2015) Increased brain uptake of venlafaxine loaded solid lipid nanoparticles by overcoming the efflux function and expression of P-gp. Arch Pharm Res 38:1325\u20131335. https:\/\/doi.org\/10.1007\/s12272-014-0539-6","journal-title":"Arch Pharm Res"},{"key":"7871_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03639045.2023.2252062","volume":"49","author":"MH Chen","year":"2023","unstructured":"Chen MH, Liu XZ, Qu XW, Guo RB, Zhang L, Kong L et al (2023) ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer\u2019s disease in APP\/PS-1 mice. Drug Dev Ind Pharm 49:559\u2013571. https:\/\/doi.org\/10.1080\/03639045.2023.2252062","journal-title":"Drug Dev Ind Pharm"},{"key":"7871_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/ijms23010102","volume":"23","author":"G Sierri","year":"2021","unstructured":"Sierri G, Dal Magro R, Vergani B, Leone BE, Formicola B, Taiarol L et al (2021) Reduced levels of ABCA1 transporter are responsible for the Cholesterol Efflux Impairment in \u03b2-Amyloid-Induced reactive astrocytes: potential rescue from biomimetic HDLs. Int J Mol Sci 23:102. https:\/\/doi.org\/10.3390\/ijms23010102","journal-title":"Int J Mol Sci"},{"key":"7871_CR56","doi-asserted-by":"publisher","first-page":"204062232210816","DOI":"10.1177\/20406223221081605","volume":"13","author":"F Vecchio","year":"2022","unstructured":"Vecchio F, Lo, Bisceglia P, Imbimbo B, Pietro, Lozupone M, Latino RR, Resta E et al (2022) Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer\u2019s disease? Ther Adv Chronic Dis 13:20406223221081604. https:\/\/doi.org\/10.1177\/20406223221081605","journal-title":"Ther Adv Chronic Dis"},{"key":"7871_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuint.2017.02.012","volume":"108","author":"E Conti","year":"2017","unstructured":"Conti E, Gregori M, Radice I, Da Re F, Grana D, Re F et al (2017) Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer\u2019s disease. Neurochem Int 108:60\u201365. https:\/\/doi.org\/10.1016\/j.neuint.2017.02.012","journal-title":"Neurochem Int"},{"key":"7871_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jconrel.2017.05.013","volume":"258","author":"S Mancini","year":"2017","unstructured":"Mancini S, Balducci C, Micotti E, Tolomeo D, Forloni G, Masserini M et al (2017) Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease. J Control Release 258:121\u2013129. https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.013","journal-title":"J Control Release"},{"key":"7871_CR59","doi-asserted-by":"publisher","first-page":"105224","DOI":"10.1016\/j.jddst.2023.105224","volume":"91","author":"AA Brianna","year":"2024","unstructured":"Brianna AA, Teow S-Y, Wu YS (2024) Nanogel-based drug delivery system as a treatment modality for diverse diseases: are we there yet? J Drug Deliv Sci Technol 91:105224. https:\/\/doi.org\/10.1016\/j.jddst.2023.105224","journal-title":"J Drug Deliv Sci Technol"},{"key":"7871_CR60","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.33218\/001c.88217","volume":"6","author":"G Devassy","year":"2023","unstructured":"Devassy G, Das D, Nair SV, Koyakutty M (2023) Injectable nanogel systems for brain drug delivery. Precis Nanomed 6:1078\u20131098. https:\/\/doi.org\/10.33218\/001c.88217","journal-title":"Precis Nanomed"},{"key":"7871_CR61","doi-asserted-by":"publisher","first-page":"e10237","DOI":"10.1016\/j.heliyon.2022.e10237","volume":"8","author":"P Arjun","year":"2022","unstructured":"Arjun P, Freeman JL, Kannan RR (2022) Neurospecific fabrication and toxicity assessment of a PNIPAM nanogel encapsulated with trans-tephrostachin for blood-brain-barrier permeability in zebrafish model. Heliyon 8:e10237. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10237","journal-title":"Heliyon"},{"key":"7871_CR62","doi-asserted-by":"publisher","first-page":"21822","DOI":"10.1021\/acsami.2c00007","volume":"14","author":"C Ye","year":"2022","unstructured":"Ye C, Cheng M, Ma L, Zhang T, Sun Z, Yu C et al (2022) Oxytocin Nanogels inhibit innate inflammatory response for early intervention in Alzheimer\u2019s Disease. ACS Appl Mater Interfaces 14:21822\u201321835. https:\/\/doi.org\/10.1021\/acsami.2c00007","journal-title":"ACS Appl Mater Interfaces"},{"key":"7871_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1021\/acs.langmuir.8b01921","volume":"35","author":"G Zhao","year":"2019","unstructured":"Zhao G, Dong X, Sun Y (2019) Self-assembled Curcumin-Poly(carboxybetaine methacrylate) conjugates: potent Nano-inhibitors against amyloid \u03b2-Protein fibrillogenesis and cytotoxicity. Langmuir 35:1846\u20131857. https:\/\/doi.org\/10.1021\/acs.langmuir.8b01921","journal-title":"Langmuir"},{"key":"7871_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","volume":"270","author":"P Picone","year":"2018","unstructured":"Picone P, Sabatino MA, Ditta LA, Amato A, San Biagio PL, Mul\u00e8 F et al (2018) Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release 270:23\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.040","journal-title":"J Control Release"},{"key":"7871_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biomaterials.2015.11.057","volume":"80","author":"P Picone","year":"2016","unstructured":"Picone P, Ditta LA, Sabatino MA, Militello V, San Biagio PL, Di Giacinto ML et al (2016) Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer\u2019s disease. Biomaterials 80:179\u2013194. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.057","journal-title":"Biomaterials"},{"key":"7871_CR66","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1038\/s41598-018-21933-6","volume":"8","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Dong X, Yan X, Liu Y, Zhang L, Sun Y (2018) Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid \u03b2-protein aggregation and cytotoxicity. Sci Rep 8:3505. https:\/\/doi.org\/10.1038\/s41598-018-21933-6","journal-title":"Sci Rep"},{"key":"7871_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.reactfunctpolym.2016.04.019","volume":"104","author":"Z Jiang","year":"2016","unstructured":"Jiang Z, Dong X, Liu H, Wang Y, Zhang L, Sun Y (2016) Multifunctionality of self-assembled nanogels of curcumin-hyaluronic acid conjugates on inhibiting amyloid \u03b2-protein fibrillation and cytotoxicity. React Funct Polym 104:22\u201329. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2016.04.019","journal-title":"React Funct Polym"},{"key":"7871_CR68","doi-asserted-by":"publisher","first-page":"940","DOI":"10.33263\/BRIAC121.940960","volume":"12","author":"S Dan","year":"2022","unstructured":"Dan S, Sharma D, Rastogi K, Shaloo, Ojha H, Pathak M et al (2022) Therapeutic and diagnostic applications of nanocomposites in the treatment Alzheimer\u2019s disease studies. Biointerface Res Appl Chem 12:940\u2013960. https:\/\/doi.org\/10.33263\/BRIAC121.940960","journal-title":"Biointerface Res Appl Chem"},{"key":"7871_CR69","doi-asserted-by":"publisher","first-page":"15717","DOI":"10.1039\/d3nr03346e","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Han M, Li J, Hu Y, Chen Y, Li J (2023) Versatile lipoprotein-inspired nanocomposites rescue Alzheimer\u2019s cognitive dysfunction by promoting A\u03b2 degradation and lessening oxidative stress. Nanoscale 15:15717\u201315729. https:\/\/doi.org\/10.1039\/d3nr03346e","journal-title":"Nanoscale"},{"key":"7871_CR70","doi-asserted-by":"publisher","first-page":"104324","DOI":"10.1016\/j.jddst.2023.104324","volume":"82","author":"X Qi","year":"2023","unstructured":"Qi X, Ye P, Xie M (2023) MoS2 quantum dots based on lipid drug delivery system for combined therapy against Alzheimer\u2019s disease. J Drug Deliv Sci Technol 82:104324. https:\/\/doi.org\/10.1016\/j.jddst.2023.104324","journal-title":"J Drug Deliv Sci Technol"},{"key":"7871_CR71","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1021\/acsami.2c19839","volume":"15","author":"Q Ren","year":"2023","unstructured":"Ren Q, Chen H, Chen Y, Song Z, Ouyang S, Lian S et al (2023) Imine-Linked Covalent Organic Framework modulates oxidative stress in Alzheimer\u2019s Disease. ACS Appl Mater Interfaces 15:4947\u20134958. https:\/\/doi.org\/10.1021\/acsami.2c19839","journal-title":"ACS Appl Mater Interfaces"},{"key":"7871_CR72","doi-asserted-by":"publisher","first-page":"2106072","DOI":"10.1002\/advs.202106072","volume":"9","author":"G Han","year":"2022","unstructured":"Han G, Bai K, Yang X, Sun C, Ji Y, Zhou J et al (2022) Drug-carrier synergy therapy for Amyloid\u2010 \u03b2 clearance and inhibition of tau phosphorylation via Biomimetic lipid Nanocomposite Assembly. Adv Sci 9:2106072. https:\/\/doi.org\/10.1002\/advs.202106072","journal-title":"Adv Sci"},{"key":"7871_CR73","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1021\/acsami.1c17861","volume":"14","author":"K Ge","year":"2022","unstructured":"Ge K, Mu Y, Liu M, Bai Z, Liu Z, Geng D et al (2022) Gold nanorods with spatial separation of CeO2 deposition for Plasmonic-enhanced antioxidant stress and Photothermal Therapy of Alzheimer\u2019s Disease. ACS Appl Mater Interfaces 14:3662\u20133674. https:\/\/doi.org\/10.1021\/acsami.1c17861","journal-title":"ACS Appl Mater Interfaces"},{"key":"7871_CR74","doi-asserted-by":"publisher","first-page":"46406","DOI":"10.1021\/acsami.1c14818","volume":"13","author":"C Li","year":"2021","unstructured":"Li C, Wang N, Zheng G, Yang L (2021) Oral administration of resveratrol-selenium-peptide nanocomposites alleviates Alzheimer\u2019s Disease-like pathogenesis by inhibiting A\u03b2 aggregation and regulating gut microbiota. ACS Appl Mater Interfaces 13:46406\u201346420. https:\/\/doi.org\/10.1021\/acsami.1c14818","journal-title":"ACS Appl Mater Interfaces"},{"key":"7871_CR75","doi-asserted-by":"publisher","first-page":"12617","DOI":"10.1021\/acs.analchem.1c02289","volume":"93","author":"L Ma","year":"2021","unstructured":"Ma L, Yang S, Ma Y, Chen Y, Wang Z, James TD et al (2021) Benzothiazolium derivative-capped silica nanocomposites for \u03b2-Amyloid ImagingIn vivo. Anal Chem 93:12617\u201312627. https:\/\/doi.org\/10.1021\/acs.analchem.1c02289","journal-title":"Anal Chem"},{"key":"7871_CR76","doi-asserted-by":"publisher","first-page":"125058","DOI":"10.1016\/j.colsurfa.2020.125058","volume":"602","author":"Y Qi","year":"2020","unstructured":"Qi Y, Yi P, He T, Song X, Liu Y, Li Q et al (2020) Quercetin-loaded selenium nanoparticles inhibit amyloid-\u03b2 aggregation and exhibit antioxidant activity. Colloids Surf Physicochem Eng Asp 602:125058. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.125058","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"7871_CR77","doi-asserted-by":"publisher","first-page":"169331","DOI":"10.1016\/j.scitotenv.2023.169331","volume":"912","author":"T-K Tran","year":"2024","unstructured":"Tran T-K, Nguyen M-K, Lin C, Hoang T-D, Nguyen T-C, Lone AM et al (2024) Review on fate, transport, toxicity and health risk of nanoparticles in natural ecosystems: emerging challenges in the modern age and solutions toward a sustainable environment. Sci Total Environ 912:169331. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.169331","journal-title":"Sci Total Environ"},{"key":"7871_CR78","doi-asserted-by":"publisher","first-page":"167697","DOI":"10.1016\/j.scitotenv.2023.167697","volume":"906","author":"R Sharma","year":"2024","unstructured":"Sharma R, Sharma N, Prashar A, Hansa A, Asgari Lajayer B, Price GW (2024) Unraveling the plethora of toxicological implications of nanoparticles on living organisms and recent insights into different remediation strategies: a comprehensive review. Sci Total Environ 906:167697. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.167697","journal-title":"Sci Total Environ"},{"key":"7871_CR79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.psep.2023.04.037","volume":"174","author":"S Mishra","year":"2023","unstructured":"Mishra S, Sundaram B (2023) Fate, transport, and toxicity of nanoparticles: an emerging pollutant on biotic factors. Process Saf Environ Prot 174:595\u2013607. https:\/\/doi.org\/10.1016\/j.psep.2023.04.037","journal-title":"Process Saf Environ Prot"},{"key":"7871_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s41810-022-00163-4","volume":"7","author":"LK Bhardwaj","year":"2023","unstructured":"Bhardwaj LK, Rath P, Choudhury M (2023) A Comprehensive Review on the classification, uses, sources of nanoparticles (NPs) and their toxicity on Health. Aerosol Sci Eng 7:69\u201386. https:\/\/doi.org\/10.1007\/s41810-022-00163-4","journal-title":"Aerosol Sci Eng"},{"key":"7871_CR81","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1039\/d3bm00271c","volume":"11","author":"J Bi","year":"2023","unstructured":"Bi J, Mo C, Li S, Huang M, Lin Y, Yuan P et al (2023) Immunotoxicity of metal and metal oxide nanoparticles: from toxic mechanisms to metabolism and outcomes. Biomater Sci 11:4151\u20134183. https:\/\/doi.org\/10.1039\/d3bm00271c","journal-title":"Biomater Sci"},{"key":"7871_CR82","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1039\/d2na00534d","volume":"5","author":"M Awashra","year":"2023","unstructured":"Awashra M, M\u0142ynarz P (2023) The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective. Nanoscale Adv 5:2674\u20132723. https:\/\/doi.org\/10.1039\/d2na00534d","journal-title":"Nanoscale Adv"},{"key":"7871_CR83","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejpb.2022.12.010","volume":"182","author":"C Saweres-Arg\u00fcelles","year":"2023","unstructured":"Saweres-Arg\u00fcelles C, Ram\u00edrez-Novillo I, Vergara-Barber\u00e1n M, Carrasco-Correa EJ, Lerma-Garc\u00eda MJ, Sim\u00f3-Alfonso EF (2023) Skin absorption of inorganic nanoparticles and their toxicity: a review. Eur J Pharm Biopharm 182:128\u2013140. https:\/\/doi.org\/10.1016\/j.ejpb.2022.12.010","journal-title":"Eur J Pharm Biopharm"},{"key":"7871_CR84","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1039\/d2ma01105k","volume":"4","author":"N Vidyasagar","year":"2023","unstructured":"Vidyasagar N, Patel RR, Singh SK, Singh M (2023) Green synthesis of silver nanoparticles: methods, biological applications, delivery and toxicity. Mater Adv 4:1831\u20131849. https:\/\/doi.org\/10.1039\/d2ma01105k","journal-title":"Mater Adv"},{"key":"7871_CR85","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jat.4320","volume":"43","author":"W Hu","year":"2023","unstructured":"Hu W, Wang C, Gao D, Liang Q (2023) Toxicity of transition metal nanoparticles: a review of different experimental models in the gastrointestinal tract. J Appl Toxicol 43:32\u201346. https:\/\/doi.org\/10.1002\/jat.4320","journal-title":"J Appl Toxicol"},{"key":"7871_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11051-020-04966-9","volume":"22","author":"B De Berardis","year":"2020","unstructured":"De Berardis B, Marchetti M, Risuglia A, Ietto F, Fanizza C, Superti F (2020) Exposure to airborne gold nanoparticles: a review of current toxicological data on the respiratory tract. J Nanoparticle Res 22:235. https:\/\/doi.org\/10.1007\/s11051-020-04966-9","journal-title":"J Nanoparticle Res"},{"key":"7871_CR87","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s41204-022-00287-5","volume":"7","author":"MM Shah","year":"2022","unstructured":"Shah MM, Ahmad K, Ahmad B, Shah SM, Masood H, Siddique MAR et al (2022) Recent trends in green synthesis of silver, gold, and zinc oxide nanoparticles and their application in nanosciences and toxicity: a review. Nanotechnol Environ Eng 7:907\u2013922. https:\/\/doi.org\/10.1007\/s41204-022-00287-5","journal-title":"Nanotechnol Environ Eng"},{"key":"7871_CR88","doi-asserted-by":"publisher","first-page":"100991","DOI":"10.1016\/j.bbrep.2021.100991","volume":"26","author":"A Sani","year":"2021","unstructured":"Sani A, Cao C, Cui D (2021) Toxicity of gold nanoparticles (AuNPs): a review. Biochem Biophys Rep 26:100991. https:\/\/doi.org\/10.1016\/j.bbrep.2021.100991","journal-title":"Biochem Biophys Rep"},{"key":"7871_CR89","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/nano11092454","volume":"11","author":"P Talarska","year":"2021","unstructured":"Talarska P, Boruczkowski M, \u017burawski J (2021) Current knowledge of silver and gold nanoparticles in Laboratory Research\u2014Application, Toxicity, Cellular Uptake. Nanomaterials 11:2454. https:\/\/doi.org\/10.3390\/nano11092454","journal-title":"Nanomaterials"},{"key":"7871_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/00914037.2021.1985495","volume":"72","author":"SR Pardeshi","year":"2023","unstructured":"Pardeshi SR, Nikam A, Chandak P, Mandale V, Naik JB, Giram PS (2023) Recent advances in PLGA based nanocarriers for drug delivery system: a state of the art review. Int J Polym Mater Polym Biomater 72:49\u201378. https:\/\/doi.org\/10.1080\/00914037.2021.1985495","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"7871_CR91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-8118-8-7","volume":"8","author":"WM Pardridge","year":"2011","unstructured":"Pardridge WM (2011) Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS 8:7. https:\/\/doi.org\/10.1186\/2045-8118-8-7","journal-title":"Fluids Barriers CNS"},{"key":"7871_CR92","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/jps.21604","volume":"98","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH (2009) Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J Pharm Sci 98:2501\u20132515. https:\/\/doi.org\/10.1002\/jps.21604","journal-title":"J Pharm Sci"},{"key":"7871_CR93","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1021\/acs.molpharmaceut.5b00088","volume":"12","author":"A Mistry","year":"2015","unstructured":"Mistry A, Stolnik S, Illum L (2015) Nose-to-brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium. Mol Pharm 12:2755\u20132766. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00088","journal-title":"Mol Pharm"},{"key":"7871_CR94","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","volume":"40","author":"RG Thorne","year":"2001","unstructured":"Thorne RG, Frey WH (2001) Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 40:907\u2013946. https:\/\/doi.org\/10.2165\/00003088-200140120-00003","journal-title":"Clin Pharmacokinet"},{"key":"7871_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/cne.10143","volume":"444","author":"TE Finger","year":"2002","unstructured":"Finger TE, B\u00f6ttger B, Schaefer ML, Silver WL (2002) Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli. J Comp Neurol 444:221\u2013226. https:\/\/doi.org\/10.1002\/cne.10143","journal-title":"J Comp Neurol"},{"key":"7871_CR96","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/mp100029t","volume":"7","author":"NJ Johnson","year":"2010","unstructured":"Johnson NJ, Hanson LR, Frey WH (2010) Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm 7:884\u2013893. https:\/\/doi.org\/10.1021\/mp100029t","journal-title":"Mol Pharm"},{"key":"7871_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1211\/0022357022764","volume":"56","author":"DS Jones","year":"2010","unstructured":"Jones DS, Craig DQM (2010) The Journal of Pharmacy and Pharmacology\u2013 four years on. J Pharm Pharmacol 56:1\u20132. https:\/\/doi.org\/10.1211\/0022357022764","journal-title":"J Pharm Pharmacol"},{"key":"7871_CR98","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","volume":"7","author":"P Arora","year":"2002","unstructured":"Arora P, Sharma S, Garg S (2002) Permeability issues in nasal drug delivery. Drug Discov Today 7:967\u2013975. https:\/\/doi.org\/10.1016\/S1359-6446(02)02452-2","journal-title":"Drug Discov Today"},{"key":"7871_CR99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1208\/pt030105","volume":"3","author":"AM Al-Ghananeem","year":"2002","unstructured":"Al-Ghananeem AM, Traboulsi AA, Dittert LW, Hussain AA (2002) Targeted brain delivery of 17\u03b2-estradiol via nasally administered water soluble prodrugs. AAPS PharmSciTech 3:5. https:\/\/doi.org\/10.1208\/pt030105","journal-title":"AAPS PharmSciTech"},{"key":"7871_CR100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379:146\u2013157. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.06.019","journal-title":"Int J Pharm"},{"key":"7871_CR101","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vetimm.2011.03.004","volume":"148","author":"A Vujanic","year":"2012","unstructured":"Vujanic A, Sutton P, Snibson KJ, Yen HH, Scheerlinck JPY (2012) Mucosal vaccination: lung versus nose. Vet Immunol Immunopathol 148:172\u2013177. https:\/\/doi.org\/10.1016\/j.vetimm.2011.03.004","journal-title":"Vet Immunol Immunopathol"},{"key":"7871_CR102","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201816666191029122740","volume":"16","author":"K Kashyap","year":"2019","unstructured":"Kashyap K, Shukla R (2019) Drug delivery and targeting to the Brain through Nasal Route: mechanisms, Applications and challenges. Curr Drug Deliv 16:887\u2013901. https:\/\/doi.org\/10.2174\/1567201816666191029122740","journal-title":"Curr Drug Deliv"},{"key":"7871_CR103","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156720112803529828","volume":"9","author":"S Gizurarson","year":"2012","unstructured":"Gizurarson S (2012) Anatomical and histological factors affecting Intranasal Drug and Vaccine Delivery. Curr Drug Deliv 9:566\u2013582. https:\/\/doi.org\/10.2174\/156720112803529828","journal-title":"Curr Drug Deliv"},{"key":"7871_CR104","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/acsomega.0c05033","volume":"6","author":"M Handa","year":"2021","unstructured":"Handa M, Ujjwal RR, Vasdev N, Flora SJS, Shukla R (2021) Optimization of surfactant- and cosurfactant-aided Pine Oil Nanoemulsions by Isothermal Low-Energy methods for anticholinesterase activity. ACS Omega 6:559\u2013568. https:\/\/doi.org\/10.1021\/acsomega.0c05033","journal-title":"ACS Omega"},{"key":"7871_CR105","first-page":"385","volume":"19","author":"P Chinna Reddy","year":"2011","unstructured":"Chinna Reddy P, Chaitanya KSC, Madhusudan Rao Y (2011) A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. DARU. J Pharm Sci 19:385\u2013403","journal-title":"J Pharm Sci"},{"key":"7871_CR106","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1023\/A:1007594602449","volume":"17","author":"D Betbeder","year":"2000","unstructured":"Betbeder D, Sp\u00e9randio S, Latapie JP, de Nada\u00ed J, Etienne A, Zajac JM et al (2000) Biovector(TM) nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm Res 17:743\u2013748. https:\/\/doi.org\/10.1023\/A:1007594602449","journal-title":"Pharm Res"},{"key":"7871_CR107","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","volume":"32","author":"NM Zaki","year":"2007","unstructured":"Zaki NM, Awad GA, Mortada ND, Abd ElHady SS (2007) Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296\u2013307. https:\/\/doi.org\/10.1016\/j.ejps.2007.08.006","journal-title":"Eur J Pharm Sci"},{"key":"7871_CR108","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1289\/ehp.9030","volume":"114","author":"A Elder","year":"2006","unstructured":"Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J et al (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114:1172\u20131178. https:\/\/doi.org\/10.1289\/ehp.9030","journal-title":"Environ Health Perspect"},{"key":"7871_CR109","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H (2016) Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 6:268\u2013286. https:\/\/doi.org\/10.1016\/j.apsb.2016.05.013","journal-title":"Acta Pharm Sin B"},{"key":"7871_CR110","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.3390\/ijms222111654","volume":"22","author":"RGR Pinheiro","year":"2021","unstructured":"Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR (2021) Nanoparticles for targeted Brain Drug Delivery: what do we know? Int J Mol Sci 22:11654. https:\/\/doi.org\/10.3390\/ijms222111654","journal-title":"Int J Mol Sci"},{"key":"7871_CR111","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neures.2020.12.003","volume":"170","author":"E Lira-Diaz","year":"2021","unstructured":"Lira-Diaz E, Gonzalez-Pedroza MG, Vasquez C, Morales-Luckie RA, Gonzalez-Perez O (2021) Gold nanoparticles produce transient reactive gliosis in the adult brain. Neurosci Res 170:76\u201386. https:\/\/doi.org\/10.1016\/j.neures.2020.12.003","journal-title":"Neurosci Res"},{"key":"7871_CR112","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1021\/tx200369s","volume":"25","author":"CJ Rivet","year":"2012","unstructured":"Rivet CJ, Yuan Y, Borca-Tasciuc DA, Gilbert RJ (2012) Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 25:153\u2013161. https:\/\/doi.org\/10.1021\/tx200369s","journal-title":"Chem Res Toxicol"},{"key":"7871_CR113","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.jddst.2020.101628","volume":"57","author":"KM Asha Spandana","year":"2020","unstructured":"Asha Spandana KM, Bhaskaran M, Karri VVSNR, Natarajan J (2020) A comprehensive review of nano drug delivery system in the treatment of CNS disorders. J Drug Deliv Sci Technol 57:101628. https:\/\/doi.org\/10.1016\/j.jddst.2020.101628","journal-title":"J Drug Deliv Sci Technol"},{"key":"7871_CR114","doi-asserted-by":"publisher","unstructured":"Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I (2020) Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer\u2019s Disease Treatment? Curr Protein Pept Sci.;21:1184\u201392. https:\/\/doi.org\/10.2174\/1389203721666200226101930","DOI":"10.2174\/1389203721666200226101930"},{"key":"7871_CR115","doi-asserted-by":"publisher","first-page":"100579","DOI":"10.1016\/j.colcom.2021.100579","volume":"46","author":"J Zhao","year":"2022","unstructured":"Zhao J, Xu N, Yang X, Ling G, Zhang P (2022) The roles of gold nanoparticles in the detection of amyloid-\u03b2 peptide for Alzheimer\u2019s disease. Colloid Interface Sci Commun 46:100579. https:\/\/doi.org\/10.1016\/j.colcom.2021.100579","journal-title":"Colloid Interface Sci Commun"},{"key":"7871_CR116","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1039\/d3tb01023f","volume":"11","author":"M Aili","year":"2023","unstructured":"Aili M, Zhou K, Zhan J, Zheng H, Luo F (2023) Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer\u2019s disease. J Mater Chem B 11:8605\u20138621. https:\/\/doi.org\/10.1039\/d3tb01023f","journal-title":"J Mater Chem B"},{"key":"7871_CR117","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ibra.12126","volume":"9","author":"E Scarpa","year":"2023","unstructured":"Scarpa E, Cascione M, Griego A, Pellegrino P, Moschetti G, De Matteis V (2023) Gold and silver nanoparticles in Alzheimer\u2019s and Parkinson\u2019s diagnostics and treatments. Ibrain 9:298\u2013315. https:\/\/doi.org\/10.1002\/ibra.12126","journal-title":"Ibrain"},{"key":"7871_CR118","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12951-023-01957-5","volume":"21","author":"K Govindarajan","year":"2023","unstructured":"Govindarajan K, Kar S (2023) Detection of \u03b2-amyloid aggregates\/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer\u2019s disease. J Nanobiotechnol 21:216. https:\/\/doi.org\/10.1186\/s12951-023-01957-5","journal-title":"J Nanobiotechnol"},{"key":"7871_CR119","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1570159x19666210823103020","volume":"20","author":"SK Shahbaz","year":"2021","unstructured":"Shahbaz SK, Koushki K, Sathyapalan T, Majeed M, Sahebkar A (2021) PLGA-Based Curcumin Delivery System: an interesting Therapeutic Approach in the treatment of Alzheimer\u2019s Disease. Curr Neuropharmacol 20:309\u2013323. https:\/\/doi.org\/10.2174\/1570159x19666210823103020","journal-title":"Curr Neuropharmacol"},{"key":"7871_CR120","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/app11094305","volume":"11","author":"L Del Amo","year":"2021","unstructured":"Del Amo L, Cano A, Ettcheto M, Souto EB, Espina M, Camins A et al (2021) Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer\u2019s Disease. Appl Sci 11:4305. https:\/\/doi.org\/10.3390\/app11094305","journal-title":"Appl Sci"},{"key":"7871_CR121","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1049\/nbt2.12127","volume":"17","author":"C Jalili","year":"2023","unstructured":"Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S et al (2023) Brain targeting based nanocarriers loaded with resveratrol in Alzheimer\u2019s disease: a review. IET Nanobiotechnol 17:154\u2013170. https:\/\/doi.org\/10.1049\/nbt2.12127","journal-title":"IET Nanobiotechnol"},{"key":"7871_CR122","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","volume":"319","author":"D Gopalan","year":"2020","unstructured":"Gopalan D, Pandey A, Udupa N, Mutalik S (2020) Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: role of surface engineered nanocarriers. J Control Release 319:183\u2013200. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.034","journal-title":"J Control Release"},{"key":"7871_CR123","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.10.034","volume":"314","author":"SD Hettiarachchi","year":"2019","unstructured":"Hettiarachchi SD, Zhou Y, Seven E, Lakshmana MK, Kaushik AK, Chand HS et al (2019) Nanoparticle-mediated approaches for Alzheimer\u2019s disease pathogenesis, diagnosis, and therapeutics. J Control Release 314:125\u2013140. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.034","journal-title":"J Control Release"},{"key":"7871_CR124","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.molpharmaceut.0c00218","volume":"17","author":"BDS Rodrigues","year":"2020","unstructured":"Rodrigues BDS, Kanekiyo T, Singh J (2020) Nerve growth factor gene delivery across the blood-brain barrier to reduce Beta amyloid Accumulation in AD mice. Mol Pharm 17:2054\u20132063. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00218","journal-title":"Mol Pharm"},{"key":"7871_CR125","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41565-019-0496-9","volume":"14","author":"HS Leong","year":"2019","unstructured":"Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Duf\u00e9s C et al (2019) On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol 14:629\u2013635. https:\/\/doi.org\/10.1038\/s41565-019-0496-9","journal-title":"Nat Nanotechnol"},{"key":"7871_CR126","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1002\/mco2.327","volume":"4","author":"L Xuan","year":"2023","unstructured":"Xuan L, Ju Z, Skonieczna M, Zhou PK, Huang R (2023) Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm 4:e327. https:\/\/doi.org\/10.1002\/mco2.327","journal-title":"MedComm"},{"key":"7871_CR127","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","volume":"38","author":"P Mukherjee","year":"2022","unstructured":"Mukherjee P, Roy S, Ghosh D, Nandi SK (2022) Role of animal models in biomedical research: a review. Lab Anim Res 38:18. https:\/\/doi.org\/10.1186\/s42826-022-00128-1","journal-title":"Lab Anim Res"},{"key":"7871_CR128","doi-asserted-by":"publisher","first-page":"e19374","DOI":"10.1016\/j.heliyon.2023.e19374","volume":"9","author":"NL Dashputre","year":"2023","unstructured":"Dashputre NL, Laddha UD, Darekar PP, Kadam JD, Patil SB, Sable RR et al (2023) Potential therapeutic effects of naringin loaded PLGA nanoparticles for the management of Alzheimer\u2019s disease: in vitro, ex vivo and in vivo investigation. Heliyon 9:e19374. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19374","journal-title":"Heliyon"},{"key":"7871_CR129","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/biomedicines10050985","volume":"10","author":"T Musumeci","year":"2022","unstructured":"Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ et al (2022) Intranasal Administration of a TRAIL neutralizing monoclonal antibody adsorbed in PLGA nanoparticles and NLC Nanosystems: an in vivo study on a mouse model of Alzheimer\u2019s Disease. Biomedicines 10:985. https:\/\/doi.org\/10.3390\/biomedicines10050985","journal-title":"Biomedicines"},{"key":"7871_CR130","doi-asserted-by":"publisher","first-page":"012001","DOI":"10.1088\/1742-6596\/1849\/1\/012001","volume":"1849","author":"SK Tripathi","year":"2021","unstructured":"Tripathi SK, Patel B, Shukla S, Pachouri C, Pathak S, Pandey A (2021) Donepezil loaded PLGA Nanoparticles, from modified Nano-Precipitation, an Advanced Drug Delivery System to treat Alzheimer Disease. J Phys Conf Ser 1849:012001. https:\/\/doi.org\/10.1088\/1742-6596\/1849\/1\/012001","journal-title":"J Phys Conf Ser"},{"key":"7871_CR131","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2147\/IJN.S236922","volume":"15","author":"R Xu","year":"2020","unstructured":"Xu R, Wang J, Xu J, Song X, Huang H, Feng Y et al (2020) Rhynchophylline loaded-mPEG-PLGA nanoparticles coated with tween-80 for preliminary study in Alzheimer\u2019s disease. Int J Nanomed 15:1149\u20131160. https:\/\/doi.org\/10.2147\/IJN.S236922","journal-title":"Int J Nanomed"},{"key":"7871_CR132","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1080\/21691401.2017.1391822","volume":"46","author":"S Sathya","year":"2018","unstructured":"Sathya S, Shanmuganathan B, Saranya S, Vaidevi S, Ruckmani K, Pandima Devi K (2018) Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer\u2019s toxic A\u03b2 peptide aggregation and fibrillation associated with impaired neuronal cell function. Artif Cells Nanomed Biotechnol 46:1719\u20131730. https:\/\/doi.org\/10.1080\/21691401.2017.1391822","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"7871_CR133","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","volume":"16","author":"E S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez E, Ettcheto M, Egea MA, Espina M, Cano A, Calpena AC et al (2018) Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization. J Nanobiotechnol 16:32. https:\/\/doi.org\/10.1186\/s12951-018-0356-z","journal-title":"J Nanobiotechnol"},{"key":"7871_CR134","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S171490","volume":"13","author":"M Silva-Abreu","year":"2018","unstructured":"Silva-Abreu M, Calpena AC, Andr\u00e9s-Benito P, Aso E, Romero IA, Roig-Carles D et al (2018) PPAR\u03b3 agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer\u2019s disease: in vitro and in vivo studies. Int J Nanomed 13:5577\u20135590. https:\/\/doi.org\/10.2147\/IJN.S171490","journal-title":"Int J Nanomed"},{"key":"7871_CR135","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.2147\/IJN.S144545","volume":"12","author":"PC Bhatt","year":"2017","unstructured":"Bhatt PC, Verma A, Al-Abbasi FA, Anwar F, Kumar V, Panda BP (2017) Development of surface-engineered PLGA nanoparticulate-delivery system of tet1-conjugated nattokinase enzyme for inhibition of A\u03b240 plaques in Alzheimer\u2019s disease. Int J Nanomed 12:8749\u20138768. https:\/\/doi.org\/10.2147\/IJN.S144545","journal-title":"Int J Nanomed"},{"key":"7871_CR136","doi-asserted-by":"publisher","first-page":"81001","DOI":"10.18632\/oncotarget.20944","volume":"8","author":"N Huang","year":"2017","unstructured":"Huang N, Lu S, Liu XG, Zhu J, Wang YJ, Liu RT (2017) PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice. Oncotarget 8:81001\u201381013. https:\/\/doi.org\/10.18632\/oncotarget.20944","journal-title":"Oncotarget"},{"key":"7871_CR137","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","volume":"145","author":"JA Loureiro","year":"2016","unstructured":"Loureiro JA, Gomes B, Fricker G, Coelho MAN, Rocha S, Pereira MC (2016) Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer\u2019s disease treatment. Colloids Surf B Biointerfaces 145:8\u201313. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.04.041","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7871_CR138","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s11671-018-2759-z","volume":"13","author":"R Yang","year":"2018","unstructured":"Yang R, Zheng Y, Wang Q, Zhao L (2018) Curcumin-loaded chitosan\u2013bovine serum albumin nanoparticles potentially enhanced A\u03b2 42 phagocytosis and modulated macrophage polarization in Alzheimer\u2019s disease. Nanoscale Res Lett 13:330. https:\/\/doi.org\/10.1186\/s11671-018-2759-z","journal-title":"Nanoscale Res Lett"},{"key":"7871_CR139","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.nano.2011.06.008","volume":"8","author":"KM Jaruszewski","year":"2012","unstructured":"Jaruszewski KM, Ramakrishnan S, Poduslo JF, Kandimalla KK (2012) Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer\u2019s disease amyloid protein. Nanomed Nanatechnol Biol Med 8:250\u2013260. https:\/\/doi.org\/10.1016\/j.nano.2011.06.008","journal-title":"Nanomed Nanatechnol Biol Med"},{"key":"7871_CR140","doi-asserted-by":"publisher","first-page":"113270","DOI":"10.1016\/j.colsurfb.2023.113270","volume":"225","author":"S Andrade","year":"2023","unstructured":"Andrade S, Pereira MC, Loureiro JA (2023) Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer\u2019s disease therapy. Colloids Surf B Biointerfaces 225:113270. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113270","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7871_CR141","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nano13040699","volume":"13","author":"F Rod\u00e0","year":"2023","unstructured":"Rod\u00e0 F, Picciolini S, Mangolini V, Gualerzi A, Seneci P, Renda A et al (2023) Raman Spectroscopy characterization of Multi-functionalized liposomes as Drug-Delivery systems for Neurological disorders. Nanomaterials 13:699. https:\/\/doi.org\/10.3390\/nano13040699","journal-title":"Nanomaterials"},{"key":"7871_CR142","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/1061186X.2023.2216405","volume":"31","author":"X Zhang","year":"2023","unstructured":"Zhang X, Shi N, Chen M, Liu M, Ju R, Liu Y et al (2023) Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer\u2019s disease-related symptoms in APP\/PS-1 mice. J Drug Target 31:634\u2013645. https:\/\/doi.org\/10.1080\/1061186X.2023.2216405","journal-title":"J Drug Target"},{"key":"7871_CR143","doi-asserted-by":"publisher","first-page":"122167","DOI":"10.1016\/j.ijpharm.2022.122167","volume":"626","author":"S Andrade","year":"2022","unstructured":"Andrade S, Ramalho MJ, Loureiro JA, Pereira MC (2022) Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer\u2019s disease therapy. Int J Pharm 626:122167. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122167","journal-title":"Int J Pharm"},{"key":"7871_CR144","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/pharmaceutics14102163","volume":"14","author":"S Andrade","year":"2022","unstructured":"Andrade S, Loureiro JA, Pereira MC (2022) Transferrin-functionalized liposomes for the delivery of gallic acid: a Therapeutic Approach for Alzheimer\u2019s Disease. Pharmaceutics 14:2163. https:\/\/doi.org\/10.3390\/pharmaceutics14102163","journal-title":"Pharmaceutics"},{"key":"7871_CR145","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1080\/10717544.2022.2072543","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J, Kong L, Guo RB, He SY, Liu XZ, Zhang L et al (2022) Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer\u2019s disease. Drug Deliv 29:1648\u20131662. https:\/\/doi.org\/10.1080\/10717544.2022.2072543","journal-title":"Drug Deliv"},{"key":"7871_CR146","doi-asserted-by":"publisher","first-page":"121095","DOI":"10.1016\/j.ijpharm.2021.121095","volume":"608","author":"S Arora","year":"2021","unstructured":"Arora S, Singh J (2021) In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy. Int J Pharm 608:121095. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121095","journal-title":"Int J Pharm"},{"key":"7871_CR147","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1208\/s12249-021-02072-0","volume":"22","author":"R Saka","year":"2021","unstructured":"Saka R, Chella N, Khan W (2021) Development of Imatinib Mesylate-Loaded liposomes for nose to Brain Delivery: in Vitro and in vivo evaluation. AAPS PharmSciTech 22:192. https:\/\/doi.org\/10.1208\/s12249-021-02072-0","journal-title":"AAPS PharmSciTech"},{"key":"7871_CR148","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1021\/acs.molpharmaceut.6b00781","volume":"13","author":"Q Song","year":"2016","unstructured":"Song Q, Song H, Xu J, Huang J, Hu M, Gu X et al (2016) Biomimetic ApoE-reconstituted high density lipoprotein nanocarrier for blood-brain barrier penetration and amyloid beta-targeting drug delivery. Mol Pharm 13:3976\u20133987. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00781","journal-title":"Mol Pharm"},{"key":"7871_CR149","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s12274-016-1108-8","volume":"9","author":"G Sancini","year":"2016","unstructured":"Sancini G, Dal Magro R, Ornaghi F, Balducci C, Forloni G, Gobbi M et al (2016) Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer\u2019s disease murine model. Nano Res 9:2190\u20132201. https:\/\/doi.org\/10.1007\/s12274-016-1108-8","journal-title":"Nano Res"},{"key":"7871_CR150","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","volume":"134","author":"JA Loureiro","year":"2015","unstructured":"Loureiro JA, Gomes B, Fricker G, Cardoso I, Ribeiro CA, Gaiteiro C et al (2015) Dual ligand immunoliposomes for drug delivery to the brain. Colloids Surf B Biointerfaces 134:213\u2013219. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.06.067","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7871_CR151","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","volume":"10","author":"L Bana","year":"2014","unstructured":"Bana L, Minniti S, Salvati E, Sesana S, Zambelli V, Cagnotto A et al (2014) Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A\u03b2 aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease. Nanomed Nanatechnol Biol Med 10:1583\u20131590. https:\/\/doi.org\/10.1016\/j.nano.2013.12.001","journal-title":"Nanomed Nanatechnol Biol Med"},{"key":"7871_CR152","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","volume":"80","author":"S Mourtas","year":"2014","unstructured":"Mourtas S, Lazar AN, Markoutsa E, Duyckaerts C, Antimisiaris SG (2014) Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem 80:175\u2013183. https:\/\/doi.org\/10.1016\/j.ejmech.2014.04.050","journal-title":"Eur J Med Chem"},{"key":"7871_CR153","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/IJN.S42783","volume":"8","author":"E Salvati","year":"2013","unstructured":"Salvati E, Re F, Sesana S, Cambianica I, Sancini G, Masserini M et al (2013) Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-\u03b2 peptide: the chemical design affects the permeability across an in vitro model. Int J Nanomed 8:1749\u20131758. https:\/\/doi.org\/10.2147\/IJN.S42783","journal-title":"Int J Nanomed"},{"key":"7871_CR154","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jbiotec.2011.06.037","volume":"156","author":"F Re","year":"2011","unstructured":"Re F, Cambianica I, Sesana S, Salvati E, Cagnotto A, Salmona M et al (2011) Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. J Biotechnol 156:341\u2013346. https:\/\/doi.org\/10.1016\/j.jbiotec.2011.06.037","journal-title":"J Biotechnol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07871-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:47:26Z","timestamp":1742320046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07871-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7871"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07871-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval is required for this article as no datasets were generated or analyzed during the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This does not apply to this article, as no datasets were generated or analyzed during the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Written consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"This literature review did not involve any original research with human participants or animals, thus informed consent was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}